Name: Name:Boc-Asp(ObBzl)-OSu
Brand: AABLOCKS
SKU: AA0017PC
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA0017PC

Chemical Name: Boc-Asp(ObBzl)-OSu

CAS Number: 13798-75-9

Molecular Formula: C20H24N2O8

Molecular Weight: 420.4132

MDL Number: MFCD00037912

SMILES: O=C(C[C@@H](C(=O)ON1C(=O)CCC1=O)NC(=O)OC(C)(C)C)OCc1ccccc1

Properties

Form: Solid

MP: 98-102 °C

Storage: Keep in dry area;2-8℃;

Complexity: 663

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 1

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 30

Hydrogen Bond Acceptor Count: 8

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 11

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.3

Downstream Synthesis Route

6066-82-6

7536-58-5

13798-75-9

[1]CurrentPatentAssignee:FEDERALSTATEUNITARYENTERPRISEOFRUSSIANFEDERATION-EP2397488,2019,B1Locationinpatent:Paragraph0171;0172

[2]Safi,Samir;Jeanson,Aurélie;Roques,Jérome;Solari,PierLorenzo;Charnay-Pouget,Florence;DenAuwer,Christophe;Creff,Gaëlle;Aitken,DavidJ.;Simoni,Eric[InorganicChemistry,2016,vol.55,#2,p.877-886]

[3]Harris,ThomasD.;Rajopadhye,Milind;Damphousse,PaulR.;Glowacka,Danuta;Yu,Karmine;Bourque,JeffreyP.;Barrett,JohnA.;Damphousse,DavidJ.;Heminway,StuartJ.;Lazewatsky,Joel;Mazaika,Theresa;Carroll,TimothyR.[BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1741-1746]

[4]Wang,Ruo;Wong,Chi-Huey[TetrahedronLetters,1996,vol.37,#31,p.5427-5430]

[5]Watanabe,Noriyuki[ChemistryLetters,1981,p.1331-1332]Yajima;Futaki;Fujii;Akaji;Funakoshi;Sakurai;Katakura;Inoue;Hosotani;Tobe[ChemicalandPharmaceuticalBulletin,1986,vol.34,#2,p.528-539]

[6]Gigot;Penninckx[JournalofPharmaceuticalSciences,1984,vol.73,#2,p.275-277]

[7]Bergeron,RaymondJ.;PhanstielIV,Otto;Yao,GuoWei;Milstein,Sam;Weimar,WilliamR.[JournaloftheAmericanChemicalSociety,1994,vol.116,#19,p.8479-8484]

[8]Takao,Koichi;Igarashi,Toshihisa;Ogiso,Hironao;Ugata,Kazuya;Shirahata,Akira;Samejima,Keijiro[ChemicalandPharmaceuticalBulletin,1998,vol.46,#7,p.1169-1172]

[9]Locationinpatent:schemeortableNakamura,Hiroyuki;Watanabe,Mizuyoshi;Ban,HyunSeung;Nabeyama,Wataru;Asai,Akira[BioorganicandMedicinalChemistryLetters,2009,vol.19,#12,p.3220-3224]

[10]Cal,Marta;Jaremko,Mariusz;Jaremko,Lukasz;Stefanowicz,Piotr[JournalofPeptideScience,2013,vol.19,#1,p.9-15]

13798-75-9

147-85-3

68939-29-7

[1]Okamoto,Kenji;Yasumura,Koichi;Fujitani,Kazuyoshi;Katakura,Shinichi;Akaji,Kenichi;etal.[Chemicalandpharmaceuticalbulletin,1984,vol.32,#2,p.430-437]

13798-75-9

13650-73-2

32886-43-4

cesiumL-prolinate

SPVFTDNSSPP

[1]Evstigneeva,R.P.;Prokuronova,E.I.;Zheltukhina,G.A.;Grigor'ev,D.N.;Niyazmatov,A.A.[DokladyChemistry,1994,vol.339,#4-6,p.251-254][Dokl.Akad.NaukSSSRSer.Khim.,1994,vol.339,#4,p.489-492]

13798-75-9

52516-30-0

3-<i>tert</i>-butoxycarbonylamino-<i>N</i>-2-(3-trifluoromethyl-phenyl)-ethyl-succinamicacidbenzylester

[1]JournalofMedicinalChemistry,2000,vol.43,p.3505-3517

13798-75-9

33208-99-0

302911-12-2

[1]JournalofMedicinalChemistry,2000,vol.43,p.3505-3517